<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36310221</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2551</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Structural Analysis of SOD1 Fibrils with Mass Spectrometry, Limited Proteolysis, and Atomic Force Microscopy (AFM).</ArticleTitle><Pagination><StartPage>481</StartPage><EndPage>495</EndPage><MedlinePgn>481-495</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-2597-2_30</ELocationID><Abstract><AbstractText>This protocol describes a method to purify SOD1 in Saccharomyces cerevisiae to characterize using ICP-MS and AFM, to agitate and fibrillate for aggregation of SOD1. The human SOD1 (hSOD1) is a 32-kDa homodimer, with one copper- and one zinc-binding site per 153-amino acid subunit. Misfolded protein aggregates are often correlated with diseases known as amyloidosis, including ALS, Alzheimer's, Parkinson's, and prion disease (Valentine and Hart, Proc Natl Acad Sci USA 100: 3617-3622, 2003; Tanzi and Bertram, Cell 120: 545-555, 2005; Soto and Pritzkow, Nat Neurosci 21:1332-1340, 2018; Sarafian et al., J Neurosci Res 95:1871-1887, 2017). Proteinaceous aggregates containing hSOD1 have frequently been found in the spinal cords of ALS patients.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Bon-Kyung</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>The Department of Chemistry and Biochemistry, School of Physical Sciences, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitelegge</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Pasarow Mass Spectrometry Laboratory, The Jane and Terry Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, USA. jpw@chem.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018625" MajorTopicYN="N">Microscopy, Atomic Force</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AFM</Keyword><Keyword MajorTopicYN="N">ALS (Amyotrophic lateral sclerosis)</Keyword><Keyword MajorTopicYN="N">Aggregation</Keyword><Keyword MajorTopicYN="N">Cu/Zn SOD1 (Superoxide dismutase1)</Keyword><Keyword MajorTopicYN="N">Fibrillation</Keyword><Keyword MajorTopicYN="N">ICP-MS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36310221</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-2597-2_30</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Valentine JS, Hart PJ (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100:3617&#x2013;3622</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0730423100</ArticleId><ArticleId IdType="pubmed">12655070</ArticleId><ArticleId IdType="pmc">152971</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer&#x2019;s disease amyloid hypothesis: a genetic perspective. Cell 120:545&#x2013;555</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.02.008</ArticleId><ArticleId IdType="pubmed">15734686</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S (2018) Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 21:1332&#x2013;1340</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId><ArticleId IdType="pmc">6432913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarafian TA, Littlejohn K, Yuan S et al (2017) Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated alpha-synuclein. J Neurosci Res 95:1871&#x2013;1887</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24024</ArticleId><ArticleId IdType="pubmed">28117497</ArticleId><ArticleId IdType="pmc">5509520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Nwadibia E, Strong CD et al (2015) The disulfide bond, but not zinc or dimerization, controls initiation and seeded growth in amyotrophic lateral sclerosis-linked Cu,Zn superoxide dismutase (SOD1) fibrillation. J Biol Chem 290:30624&#x2013;30636</Citation></Reference><Reference><Citation>Chan PK, Chattopadhyay M, Sharma S et al (2013) Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy. Proc Natl Acad Sci USA 110:10934&#x2013;10939</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1309613110</ArticleId><ArticleId IdType="pubmed">23781106</ArticleId><ArticleId IdType="pmc">3704032</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine JS, Doucette PA, Zittin Potter S (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563&#x2013;593</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Valentine JS (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal 11:1603&#x2013;1614</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId><ArticleId IdType="pubmed">19271992</ArticleId><ArticleId IdType="pmc">2842589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Durazo A, Sohn SH et al (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105:18663&#x2013;18668</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807058105</ArticleId><ArticleId IdType="pubmed">19022905</ArticleId><ArticleId IdType="pmc">2585484</ArticleId></ArticleIdList></Reference><Reference><Citation>Toichi K, Yamanaka K, Furukawa Y (2013) Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis. J Biol Chem 288:4970&#x2013;4980</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.414235</ArticleId><ArticleId IdType="pubmed">23264618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough MA, Grossmann JG, Antonyuk SV et al (2004) Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc Natl Acad Sci USA 101:5976&#x2013;5981</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0305143101</ArticleId><ArticleId IdType="pubmed">15056757</ArticleId><ArticleId IdType="pmc">395908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedau-Pazos M, Goto JJ, Rabizadeh S et al (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271:515&#x2013;518</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.271.5248.515</ArticleId><ArticleId IdType="pubmed">8560268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Y, Chattopadhyay M, Whitelegge J et al (2012) SOD1 aggregation and ALS: role of metallation states and disulfide status. Curr Top Med Chem 12:2560&#x2013;2572</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026611212220010</ArticleId><ArticleId IdType="pubmed">23339308</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook J, Fritsch EF, Maniatis T (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York, NY</Citation></Reference><Reference><Citation>Goto JJ, Zhu H, Sanchez RJ et al (2000) Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem 275:1007&#x2013;1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.2.1007</ArticleId><ArticleId IdType="pubmed">10625639</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BF, Lelie HL, Durazo A et al (2008) Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1. J Biol Chem 283:8340&#x2013;8350</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M707751200</ArticleId><ArticleId IdType="pubmed">18192269</ArticleId><ArticleId IdType="pmc">2276386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermingham-McDonogh O, Gralla EB, Valentine JS (1988) The copper, zinc-superoxide dismutase gene of Saccharomyces cerevisiae: cloning, sequencing, and biological activity. Proc Natl Acad Sci USA 85:4789&#x2013;4793</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.13.4789</ArticleId><ArticleId IdType="pubmed">3290902</ArticleId><ArticleId IdType="pmc">280521</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralla EB, Valentine JS (1991) Null mutants of Saccharomyces cerevisiae Cu,Zn superoxide dismutase: characterization and spontaneous mutation rates. J Bacteriol 173:5918&#x2013;5920</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jb.173.18.5918-5920.1991</ArticleId><ArticleId IdType="pubmed">1885557</ArticleId><ArticleId IdType="pmc">208328</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucette PA, Whitson LJ, Cao X et al (2004) Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability. J Biol Chem 279:54558&#x2013;54566</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409744200</ArticleId><ArticleId IdType="pubmed">15485869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill JE, Myers AM, Koerner TJ et al (1986) Yeast/E. coli shuttle vectors with multiple unique restriction sites. Yeast 2:163&#x2013;167</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.320020304</ArticleId><ArticleId IdType="pubmed">3333305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabizadeh S, Gralla EB, Borchelt DR et al (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 92:3024&#x2013;3028</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.7.3024</ArticleId><ArticleId IdType="pubmed">7708768</ArticleId><ArticleId IdType="pmc">42351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei JP, Srinivasan C, Han H et al (2001) Evidence for a novel role of copper-zinc superoxide dismutase in zinc metabolism. J Biol Chem 276:44798&#x2013;44803</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104708200</ArticleId><ArticleId IdType="pubmed">11581253</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumer KM, Koone JC, Shaw BF (2020) Kinetic variability in seeded formation of ALS-linked SOD1 fibrils across multiple generations. ACS Chem Neurosci 11:304&#x2013;313</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00464</ArticleId><ArticleId IdType="pubmed">31895541</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolvahabi A, Shi Y, Rasouli S et al (2017) How do gyrating beads accelerate amyloid fibrillization? Biophys J 112:250&#x2013;264</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.12.004</ArticleId><ArticleId IdType="pubmed">28122213</ArticleId><ArticleId IdType="pmc">5266089</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>